Condition: Anaphylaxis · Sponsor: Charite University, Berlin, Germany
The Anaphylaxis Registry aims to assess data in a standardized form about symptoms, triggers, cofactors and therapy management from patients who experienced an anaphylactic reaction. This should improve diagnosis and long-term management of these life-threatening allergic reactions.
This description comes directly from the study's public registry record.
Margitta Worm, Prof. · +49 30 450 518105 · margitta.worm@charite.de
Sabine Dölle-Bierke, PhD · +49 30 450 518367 · sabine.doelle@charite.de
Always discuss trial participation with your own doctor first.
| Charité - Universitätsmedizin Berlin | Berlin, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05210543